世界および中国の人工臓器・医療用バイオニクス市場の洞察、2027年までの予測Global and China Artificial Vital Organs and Medical Bionics Market Insights, Forecast to 2027 人工臓器とは、天然の臓器の代わりに、特定の機能や関連する機能を複製または増強して、患者ができるだけ早く通常の生活に戻れるようにする目的で、人体に移植または統合される装置のことであり、バイオニクスと... もっと見る
※当ページの内容はウェブ更新時の情報です。
サマリー人工臓器とは、天然の臓器の代わりに、特定の機能や関連する機能を複製または増強して、患者ができるだけ早く通常の生活に戻れるようにする目的で、人体に移植または統合される装置のことであり、バイオニクスとは、自然界に存在する生物学的手法やシステムを、工学システムや現代技術の研究や設計に応用することである。臓器移植を待つ患者の死亡率が上昇していることから、人工臓器の需要が高まっている。臓器移植を待つ患者と提供可能な臓器とのギャップが大きくなっていることから、人工臓器と医療用バイオニクスの市場は世界的に大きな成長を遂げています。市場分析と洞察。世界および中国の人工臓器・医療用バイオニクス市場 本レポートでは、世界と中国の人工臓器・医療用バイオニクス市場に焦点を当てています。 2020年の人工臓器・医療用バイオニクスの世界市場規模はXX百万米ドルで、2021-2027年の間にXX%のCAGRで2027年末にはXX百万米ドルに達すると予想されています。中国では、人工バイタル臓器と医療用バイオニクスの市場規模は、2020年のXX百万米ドルから2027年にはXX百万米ドルまで、予測期間中にXX%のCAGRで成長すると予測されています。 世界の人工バイタル臓器・医療用バイオニクスの範囲と市場規模 Artificial Vital Organs and Medical Bionics市場は、地域(国)別、プレイヤー別、タイプ別、アプリケーション別に分類されています。世界のArtificial Vital Organs and Medical Bionics市場のプレーヤー、ステークホルダー、その他の参加者は、本レポートを強力なリソースとして活用することで、優位に立つことができるでしょう。セグメント別分析では、地域(国)別、タイプ別、アプリケーション別に、2016年から2027年までの収益と予測に焦点を当てています。 中国市場については、2016年から2027年の期間で、プレーヤー別、タイプ別、アプリケーション別の人工臓器と医療用バイオニクスの市場規模に焦点を当てています。主要プレイヤーには、中国で重要な役割を果たしているグローバルプレイヤーとローカルプレイヤーが含まれています。 タイプ別セグメント 人工バイタルオルガン バイオニクス 用途別セグメント 病院 クリニック その他 地域別 北アメリカ 米国 カナダ ヨーロッパ ドイツ フランス イギリス イタリア ロシア アジアパシフィック 中国 日本 韓国 インド オーストラリア 台湾 インドネシア タイ マレーシア フィリピン ベトナム ラテンアメリカ メキシコ ブラジル アルゼンチン 中近東・アフリカ トルコ サウジアラビア U.A.E. 会社別 アボット Abiomed, Inc. 旭化成メディカル株式会社 バクスター サイバニクス・インク エドワーズ Ekso Bionics ロシュ フレゼニウス バクスター・インターナショナル イウォーク ジャービックハート メドトロニック マイクロメッド・カーディオグラフィック 日機装 Ossur Hf オットーボック セカンドサイト・メディカル・プロダクツ社 シンカルディア・システムズ社 Thoratec Corporation Touch Bionics, Inc. Vital Therapies, Inc. WorldHeart Corporation 目次1 Study Coverage1.1 Artificial Vital Organs and Medical Bionics Product Introduction 1.2 Market by Type 1.2.1 Global Artificial Vital Organs and Medical Bionics Market Size Growth Rate by Type 1.2.2 Artificial Vital Organs 1.2.3 Bionics 1.3 Market by Application 1.3.1 Global Artificial Vital Organs and Medical Bionics Market Size Growth Rate by Application 1.3.2 Hospitals 1.3.3 Clinics 1.3.4 Others 1.4 Study Objectives 1.5 Years Considered 2 Executive Summary 2.1 Global Artificial Vital Organs and Medical Bionics Market Size, Estimates and Forecasts 2.1.1 Global Artificial Vital Organs and Medical Bionics Revenue 2016-2027 2.1.2 Global Artificial Vital Organs and Medical Bionics Sales 2016-2027 2.2 Global Artificial Vital Organs and Medical Bionics, Market Size by Region: 2016 VS 2021 VS 2027 2.3 Artificial Vital Organs and Medical Bionics Historical Market Size by Region (2016-2021) 2.3.1 Global Artificial Vital Organs and Medical Bionics Retrospective Market Scenario in Sales by Region: 2016-2021 2.3.2 Global Artificial Vital Organs and Medical Bionics Retrospective Market Scenario in Revenue by Region: 2016-2021 2.4 Artificial Vital Organs and Medical Bionics Market Estimates and Projections by Region (2022-2027) 2.4.1 Global Artificial Vital Organs and Medical Bionics Sales Forecast by Region (2022-2027) 2.4.2 Global Artificial Vital Organs and Medical Bionics Revenue Forecast by Region (2022-2027) 3 Global Artificial Vital Organs and Medical Bionics Competitor Landscape by Players 3.1 Global Top Artificial Vital Organs and Medical Bionics Manufacturers by Sales 3.1.1 Global Artificial Vital Organs and Medical Bionics Sales by Manufacturer (2016-2021) 3.1.2 Global Artificial Vital Organs and Medical Bionics Sales Market Share by Manufacturer (2016-2021) 3.2 Global Top Artificial Vital Organs and Medical Bionics Manufacturers by Revenue 3.2.1 Key Artificial Vital Organs and Medical Bionics Manufacturers Covered: Ranking by Revenue 3.2.2 Global Artificial Vital Organs and Medical Bionics Revenue by Manufacturers (2016-2021) 3.2.3 Global Artificial Vital Organs and Medical Bionics Revenue Share by Manufacturers (2016-2021) 3.2.4 Global Artificial Vital Organs and Medical Bionics Market Concentration Ratio (CR5 and HHI) (2016-2021) 3.2.5 Global Top 10 and Top 5 Companies by Artificial Vital Organs and Medical Bionics Revenue in 2020 3.2.6 Global Artificial Vital Organs and Medical Bionics Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Global Artificial Vital Organs and Medical Bionics Price by Manufacturers 3.4 Global Artificial Vital Organs and Medical Bionics Manufacturing Base Distribution, Product Types 3.4.1 Artificial Vital Organs and Medical Bionics Manufacturers Manufacturing Base Distribution, Headquarters 3.4.2 Manufacturers Artificial Vital Organs and Medical Bionics Product Type 3.4.3 Date of International Manufacturers Enter into Artificial Vital Organs and Medical Bionics Market 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type (2016-2027) 4.1 Global Artificial Vital Organs and Medical Bionics Market Size by Type (2016-2021) 4.1.1 Global Artificial Vital Organs and Medical Bionics Sales by Type (2016-2021) 4.1.2 Global Artificial Vital Organs and Medical Bionics Revenue by Type (2016-2021) 4.1.3 Artificial Vital Organs and Medical Bionics Average Selling Price (ASP) by Type (2016-2021) 4.2 Global Artificial Vital Organs and Medical Bionics Market Size Forecast by Type (2022-2027) 4.2.1 Global Artificial Vital Organs and Medical Bionics Sales Forecast by Type (2022-2027) 4.2.2 Global Artificial Vital Organs and Medical Bionics Revenue Forecast by Type (2022-2027) 4.2.3 Artificial Vital Organs and Medical Bionics Average Selling Price (ASP) Forecast by Type (2022-2027) 5 Breakdown Data by Application (2016-2027) 5.1 Global Artificial Vital Organs and Medical Bionics Market Size by Application (2016-2021) 5.1.1 Global Artificial Vital Organs and Medical Bionics Sales by Application (2016-2021) 5.1.2 Global Artificial Vital Organs and Medical Bionics Revenue by Application (2016-2021) 5.1.3 Artificial Vital Organs and Medical Bionics Price by Application (2016-2021) 5.2 Artificial Vital Organs and Medical Bionics Market Size Forecast by Application (2022-2027) 5.2.1 Global Artificial Vital Organs and Medical Bionics Sales Forecast by Application (2022-2027) 5.2.2 Global Artificial Vital Organs and Medical Bionics Revenue Forecast by Application (2022-2027) 5.2.3 Global Artificial Vital Organs and Medical Bionics Price Forecast by Application (2022-2027) 6 China by Players, Type and Application 6.1 China Artificial Vital Organs and Medical Bionics Market Size YoY Growth 2016-2027 6.1.1 China Artificial Vital Organs and Medical Bionics Sales YoY Growth 2016-2027 6.1.2 China Artificial Vital Organs and Medical Bionics Revenue YoY Growth 2016-2027 6.1.3 China Artificial Vital Organs and Medical Bionics Market Share in Global Market 2016-2027 6.2 China Artificial Vital Organs and Medical Bionics Market Size by Players (International and Local Players) 6.2.1 China Top Artificial Vital Organs and Medical Bionics Players by Sales (2016-2021) 6.2.2 China Top Artificial Vital Organs and Medical Bionics Players by Revenue (2016-2021) 6.3 China Artificial Vital Organs and Medical Bionics Historic Market Review by Type (2016-2021) 6.3.1 China Artificial Vital Organs and Medical Bionics Sales Market Share by Type (2016-2021) 6.3.2 China Artificial Vital Organs and Medical Bionics Revenue Market Share by Type (2016-2021) 6.3.3 China Artificial Vital Organs and Medical Bionics Price by Type (2016-2021) 6.4 China Artificial Vital Organs and Medical Bionics Market Estimates and Forecasts by Type (2022-2027) 6.4.1 China Artificial Vital Organs and Medical Bionics Sales Forecast by Type (2022-2027) 6.4.2 China Artificial Vital Organs and Medical Bionics Revenue Forecast by Type (2022-2027) 6.4.3 China Artificial Vital Organs and Medical Bionics Price Forecast by Type (2022-2027) 6.5 China Artificial Vital Organs and Medical Bionics Historic Market Review by Application (2016-2021) 6.5.1 China Artificial Vital Organs and Medical Bionics Sales Market Share by Application (2016-2021) 6.5.2 China Artificial Vital Organs and Medical Bionics Revenue Market Share by Application (2016-2021) 6.5.3 China Artificial Vital Organs and Medical Bionics Price by Application (2016-2021) 6.6 China Artificial Vital Organs and Medical Bionics Market Estimates and Forecasts by Application (2022-2027) 6.6.1 China Artificial Vital Organs and Medical Bionics Sales Forecast by Application (2022-2027) 6.6.2 China Artificial Vital Organs and Medical Bionics Revenue Forecast by Application (2022-2027) 6.6.3 China Artificial Vital Organs and Medical Bionics Price Forecast by Application (2022-2027) 7 North America 7.1 North America Artificial Vital Organs and Medical Bionics Market Size YoY Growth 2016-2027 7.2 North America Artificial Vital Organs and Medical Bionics Market Facts & Figures by Country 7.2.1 North America Artificial Vital Organs and Medical Bionics Sales by Country (2016-2021) 7.2.2 North America Artificial Vital Organs and Medical Bionics Revenue by Country (2016-2021) 7.2.3 U.S. 7.2.4 Canada 8 Asia Pacific 8.1 Asia Pacific Artificial Vital Organs and Medical Bionics Market Size YoY Growth 2016-2027 8.2 Asia Pacific Artificial Vital Organs and Medical Bionics Market Facts & Figures by Region 8.2.1 Asia Pacific Artificial Vital Organs and Medical Bionics Sales by Region (2016-2021) 8.2.2 Asia Pacific Artificial Vital Organs and Medical Bionics Revenue by Region (2016-2021) 8.2.3 China 8.2.4 Japan 8.2.5 South Korea 8.2.6 India 8.2.7 Australia 8.2.8 Australia 8.2.9 Indonesia 8.2.10 Thailand 8.2.11 Malaysia 8.2.12 Philippines 8.2.13 Vietnam 9 Europe 9.1 Europe Artificial Vital Organs and Medical Bionics Market Size YoY Growth 2016-2027 9.2 Europe Artificial Vital Organs and Medical Bionics Market Facts & Figures by Country 9.2.1 Europe Artificial Vital Organs and Medical Bionics Sales by Country (2016-2021) 9.2.2 Europe Artificial Vital Organs and Medical Bionics Revenue by Country (2016-2021) 9.2.3 Germany 9.2.4 France 9.2.5 U.K. 9.2.6 Italy 10 Latin America 10.1 Latin America Artificial Vital Organs and Medical Bionics Market Size YoY Growth 2016-2027 10.2 Latin America Artificial Vital Organs and Medical Bionics Market Facts & Figures by Country 10.2.1 Latin America Artificial Vital Organs and Medical Bionics Sales by Country (2016-2021) 10.2.2 Latin America Artificial Vital Organs and Medical Bionics Revenue by Country (2016-2021) 10.2.3 Mexico 10.2.4 Brazil 10.2.5 Argentina 11 Middle East and Africa 11.1 Middle East and Africa Artificial Vital Organs and Medical Bionics Market Size YoY Growth 2016-2027 11.2 Middle East and Africa Artificial Vital Organs and Medical Bionics Market Facts & Figures by Country 11.2.1 Middle East and Africa Artificial Vital Organs and Medical Bionics Sales by Country (2016-2021) 11.2.2 Middle East and Africa Artificial Vital Organs and Medical Bionics Revenue by Country (2016-2021) 11.2.3 Turkey 11.2.4 Saudi Arabia 11.2.5 U.A.E 12 Company Profiles 12.1 Abbott 12.1.1 Abbott Corporation Information 12.1.2 Abbott Description and Business Overview 12.1.3 Abbott Artificial Vital Organs and Medical Bionics Sales, Revenue and Gross Margin (2016-2021) 12.1.4 Abbott Artificial Vital Organs and Medical Bionics Products Offered 12.1.5 Abbott Recent Development 12.2 Abiomed, Inc. 12.2.1 Abiomed, Inc. Corporation Information 12.2.2 Abiomed, Inc. Description and Business Overview 12.2.3 Abiomed, Inc. Artificial Vital Organs and Medical Bionics Sales, Revenue and Gross Margin (2016-2021) 12.2.4 Abiomed, Inc. Artificial Vital Organs and Medical Bionics Products Offered 12.2.5 Abiomed, Inc. Recent Development 12.3 Asahi Kasei Medical Co., Ltd. 12.3.1 Asahi Kasei Medical Co., Ltd. Corporation Information 12.3.2 Asahi Kasei Medical Co., Ltd. Description and Business Overview 12.3.3 Asahi Kasei Medical Co., Ltd. Artificial Vital Organs and Medical Bionics Sales, Revenue and Gross Margin (2016-2021) 12.3.4 Asahi Kasei Medical Co., Ltd. Artificial Vital Organs and Medical Bionics Products Offered 12.3.5 Asahi Kasei Medical Co., Ltd. Recent Development 12.4 Baxter 12.4.1 Baxter Corporation Information 12.4.2 Baxter Description and Business Overview 12.4.3 Baxter Artificial Vital Organs and Medical Bionics Sales, Revenue and Gross Margin (2016-2021) 12.4.4 Baxter Artificial Vital Organs and Medical Bionics Products Offered 12.4.5 Baxter Recent Development 12.5 Cyberonics, Inc. 12.5.1 Cyberonics, Inc. Corporation Information 12.5.2 Cyberonics, Inc. Description and Business Overview 12.5.3 Cyberonics, Inc. Artificial Vital Organs and Medical Bionics Sales, Revenue and Gross Margin (2016-2021) 12.5.4 Cyberonics, Inc. Artificial Vital Organs and Medical Bionics Products Offered 12.5.5 Cyberonics, Inc. Recent Development 12.6 Edwards 12.6.1 Edwards Corporation Information 12.6.2 Edwards Description and Business Overview 12.6.3 Edwards Artificial Vital Organs and Medical Bionics Sales, Revenue and Gross Margin (2016-2021) 12.6.4 Edwards Artificial Vital Organs and Medical Bionics Products Offered 12.6.5 Edwards Recent Development 12.7 Ekso Bionics 12.7.1 Ekso Bionics Corporation Information 12.7.2 Ekso Bionics Description and Business Overview 12.7.3 Ekso Bionics Artificial Vital Organs and Medical Bionics Sales, Revenue and Gross Margin (2016-2021) 12.7.4 Ekso Bionics Artificial Vital Organs and Medical Bionics Products Offered 12.7.5 Ekso Bionics Recent Development 12.8 Roche 12.8.1 Roche Corporation Information 12.8.2 Roche Description and Business Overview 12.8.3 Roche Artificial Vital Organs and Medical Bionics Sales, Revenue and Gross Margin (2016-2021) 12.8.4 Roche Artificial Vital Organs and Medical Bionics Products Offered 12.8.5 Roche Recent Development 12.9 Fresenius 12.9.1 Fresenius Corporation Information 12.9.2 Fresenius Description and Business Overview 12.9.3 Fresenius Artificial Vital Organs and Medical Bionics Sales, Revenue and Gross Margin (2016-2021) 12.9.4 Fresenius Artificial Vital Organs and Medical Bionics Products Offered 12.9.5 Fresenius Recent Development 12.10 Baxter International 12.10.1 Baxter International Corporation Information 12.10.2 Baxter International Description and Business Overview 12.10.3 Baxter International Artificial Vital Organs and Medical Bionics Sales, Revenue and Gross Margin (2016-2021) 12.10.4 Baxter International Artificial Vital Organs and Medical Bionics Products Offered 12.10.5 Baxter International Recent Development 12.11 Abbott 12.11.1 Abbott Corporation Information 12.11.2 Abbott Description and Business Overview 12.11.3 Abbott Artificial Vital Organs and Medical Bionics Sales, Revenue and Gross Margin (2016-2021) 12.11.4 Abbott Artificial Vital Organs and Medical Bionics Products Offered 12.11.5 Abbott Recent Development 12.12 Jarvik Heart 12.12.1 Jarvik Heart Corporation Information 12.12.2 Jarvik Heart Description and Business Overview 12.12.3 Jarvik Heart Artificial Vital Organs and Medical Bionics Sales, Revenue and Gross Margin (2016-2021) 12.12.4 Jarvik Heart Products Offered 12.12.5 Jarvik Heart Recent Development 12.13 Medtronic 12.13.1 Medtronic Corporation Information 12.13.2 Medtronic Description and Business Overview 12.13.3 Medtronic Artificial Vital Organs and Medical Bionics Sales, Revenue and Gross Margin (2016-2021) 12.13.4 Medtronic Products Offered 12.13.5 Medtronic Recent Development 12.14 Micromed Cardiovascular 12.14.1 Micromed Cardiovascular Corporation Information 12.14.2 Micromed Cardiovascular Description and Business Overview 12.14.3 Micromed Cardiovascular Artificial Vital Organs and Medical Bionics Sales, Revenue and Gross Margin (2016-2021) 12.14.4 Micromed Cardiovascular Products Offered 12.14.5 Micromed Cardiovascular Recent Development 12.15 Nikkiso 12.15.1 Nikkiso Corporation Information 12.15.2 Nikkiso Description and Business Overview 12.15.3 Nikkiso Artificial Vital Organs and Medical Bionics Sales, Revenue and Gross Margin (2016-2021) 12.15.4 Nikkiso Products Offered 12.15.5 Nikkiso Recent Development 12.16 Ossur Hf 12.16.1 Ossur Hf Corporation Information 12.16.2 Ossur Hf Description and Business Overview 12.16.3 Ossur Hf Artificial Vital Organs and Medical Bionics Sales, Revenue and Gross Margin (2016-2021) 12.16.4 Ossur Hf Products Offered 12.16.5 Ossur Hf Recent Development 12.17 Ottobock 12.17.1 Ottobock Corporation Information 12.17.2 Ottobock Description and Business Overview 12.17.3 Ottobock Artificial Vital Organs and Medical Bionics Sales, Revenue and Gross Margin (2016-2021) 12.17.4 Ottobock Products Offered 12.17.5 Ottobock Recent Development 12.18 Second Sight Medical Products, Inc. 12.18.1 Second Sight Medical Products, Inc. Corporation Information 12.18.2 Second Sight Medical Products, Inc. Description and Business Overview 12.18.3 Second Sight Medical Products, Inc. Artificial Vital Organs and Medical Bionics Sales, Revenue and Gross Margin (2016-2021) 12.18.4 Second Sight Medical Products, Inc. Products Offered 12.18.5 Second Sight Medical Products, Inc. Recent Development 12.19 Syncardia Systems, Inc. 12.19.1 Syncardia Systems, Inc. Corporation Information 12.19.2 Syncardia Systems, Inc. Description and Business Overview 12.19.3 Syncardia Systems, Inc. Artificial Vital Organs and Medical Bionics Sales, Revenue and Gross Margin (2016-2021) 12.19.4 Syncardia Systems, Inc. Products Offered 12.19.5 Syncardia Systems, Inc. Recent Development 12.20 Thoratec Corporation 12.20.1 Thoratec Corporation Corporation Information 12.20.2 Thoratec Corporation Description and Business Overview 12.20.3 Thoratec Corporation Artificial Vital Organs and Medical Bionics Sales, Revenue and Gross Margin (2016-2021) 12.20.4 Thoratec Corporation Products Offered 12.20.5 Thoratec Corporation Recent Development 12.21 Touch Bionics, Inc. 12.21.1 Touch Bionics, Inc. Corporation Information 12.21.2 Touch Bionics, Inc. Description and Business Overview 12.21.3 Touch Bionics, Inc. Artificial Vital Organs and Medical Bionics Sales, Revenue and Gross Margin (2016-2021) 12.21.4 Touch Bionics, Inc. Products Offered 12.21.5 Touch Bionics, Inc. Recent Development 12.22 Vital Therapies, Inc. 12.22.1 Vital Therapies, Inc. Corporation Information 12.22.2 Vital Therapies, Inc. Description and Business Overview 12.22.3 Vital Therapies, Inc. Artificial Vital Organs and Medical Bionics Sales, Revenue and Gross Margin (2016-2021) 12.22.4 Vital Therapies, Inc. Products Offered 12.22.5 Vital Therapies, Inc. Recent Development 12.23 WorldHeart Corporation 12.23.1 WorldHeart Corporation Corporation Information 12.23.2 WorldHeart Corporation Description and Business Overview 12.23.3 WorldHeart Corporation Artificial Vital Organs and Medical Bionics Sales, Revenue and Gross Margin (2016-2021) 12.23.4 WorldHeart Corporation Products Offered 12.23.5 WorldHeart Corporation Recent Development 13 Market Opportunities, Challenges, Risks and Influences Factors Analysis 13.1 Artificial Vital Organs and Medical Bionics Industry Trends 13.2 Artificial Vital Organs and Medical Bionics Market Drivers 13.3 Artificial Vital Organs and Medical Bionics Market Challenges 13.4 Artificial Vital Organs and Medical Bionics Market Restraints 14 Value Chain and Sales Channels Analysis 14.1 Value Chain Analysis 14.2 Artificial Vital Organs and Medical Bionics Customers 14.3 Sales Channels Analysis 14.3.1 Sales Channels 14.3.2 Distributors 15 Research Findings and Conclusion 16 Appendix 16.1 Research Methodology 16.1.1 Methodology/Research Approach 16.1.2 Data Source 16.2 Author Details 16.3 Disclaimer
SummaryThe artificial organs are devices implanted or integrated into a human body in order to replace a natural organ, for the purpose of duplicating or augmenting a specific function or a group of related functions for the patient to return to a normal life as soon as possible, whereas bionics is the application of biological methods and systems found in nature to the study and design of engineering systems and modern technology. The increasing mortality rate of patients awaiting organ transplant has intensified the demand for artificial organs. The artificial vital organs and medical bionics market is undergoing impressive growth across the globe due to increase in the gap between patients awaiting organ transplant and the availability of donor organs. Table of Contents1 Study Coverage1.1 Artificial Vital Organs and Medical Bionics Product Introduction 1.2 Market by Type 1.2.1 Global Artificial Vital Organs and Medical Bionics Market Size Growth Rate by Type 1.2.2 Artificial Vital Organs 1.2.3 Bionics 1.3 Market by Application 1.3.1 Global Artificial Vital Organs and Medical Bionics Market Size Growth Rate by Application 1.3.2 Hospitals 1.3.3 Clinics 1.3.4 Others 1.4 Study Objectives 1.5 Years Considered 2 Executive Summary 2.1 Global Artificial Vital Organs and Medical Bionics Market Size, Estimates and Forecasts 2.1.1 Global Artificial Vital Organs and Medical Bionics Revenue 2016-2027 2.1.2 Global Artificial Vital Organs and Medical Bionics Sales 2016-2027 2.2 Global Artificial Vital Organs and Medical Bionics, Market Size by Region: 2016 VS 2021 VS 2027 2.3 Artificial Vital Organs and Medical Bionics Historical Market Size by Region (2016-2021) 2.3.1 Global Artificial Vital Organs and Medical Bionics Retrospective Market Scenario in Sales by Region: 2016-2021 2.3.2 Global Artificial Vital Organs and Medical Bionics Retrospective Market Scenario in Revenue by Region: 2016-2021 2.4 Artificial Vital Organs and Medical Bionics Market Estimates and Projections by Region (2022-2027) 2.4.1 Global Artificial Vital Organs and Medical Bionics Sales Forecast by Region (2022-2027) 2.4.2 Global Artificial Vital Organs and Medical Bionics Revenue Forecast by Region (2022-2027) 3 Global Artificial Vital Organs and Medical Bionics Competitor Landscape by Players 3.1 Global Top Artificial Vital Organs and Medical Bionics Manufacturers by Sales 3.1.1 Global Artificial Vital Organs and Medical Bionics Sales by Manufacturer (2016-2021) 3.1.2 Global Artificial Vital Organs and Medical Bionics Sales Market Share by Manufacturer (2016-2021) 3.2 Global Top Artificial Vital Organs and Medical Bionics Manufacturers by Revenue 3.2.1 Key Artificial Vital Organs and Medical Bionics Manufacturers Covered: Ranking by Revenue 3.2.2 Global Artificial Vital Organs and Medical Bionics Revenue by Manufacturers (2016-2021) 3.2.3 Global Artificial Vital Organs and Medical Bionics Revenue Share by Manufacturers (2016-2021) 3.2.4 Global Artificial Vital Organs and Medical Bionics Market Concentration Ratio (CR5 and HHI) (2016-2021) 3.2.5 Global Top 10 and Top 5 Companies by Artificial Vital Organs and Medical Bionics Revenue in 2020 3.2.6 Global Artificial Vital Organs and Medical Bionics Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Global Artificial Vital Organs and Medical Bionics Price by Manufacturers 3.4 Global Artificial Vital Organs and Medical Bionics Manufacturing Base Distribution, Product Types 3.4.1 Artificial Vital Organs and Medical Bionics Manufacturers Manufacturing Base Distribution, Headquarters 3.4.2 Manufacturers Artificial Vital Organs and Medical Bionics Product Type 3.4.3 Date of International Manufacturers Enter into Artificial Vital Organs and Medical Bionics Market 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type (2016-2027) 4.1 Global Artificial Vital Organs and Medical Bionics Market Size by Type (2016-2021) 4.1.1 Global Artificial Vital Organs and Medical Bionics Sales by Type (2016-2021) 4.1.2 Global Artificial Vital Organs and Medical Bionics Revenue by Type (2016-2021) 4.1.3 Artificial Vital Organs and Medical Bionics Average Selling Price (ASP) by Type (2016-2021) 4.2 Global Artificial Vital Organs and Medical Bionics Market Size Forecast by Type (2022-2027) 4.2.1 Global Artificial Vital Organs and Medical Bionics Sales Forecast by Type (2022-2027) 4.2.2 Global Artificial Vital Organs and Medical Bionics Revenue Forecast by Type (2022-2027) 4.2.3 Artificial Vital Organs and Medical Bionics Average Selling Price (ASP) Forecast by Type (2022-2027) 5 Breakdown Data by Application (2016-2027) 5.1 Global Artificial Vital Organs and Medical Bionics Market Size by Application (2016-2021) 5.1.1 Global Artificial Vital Organs and Medical Bionics Sales by Application (2016-2021) 5.1.2 Global Artificial Vital Organs and Medical Bionics Revenue by Application (2016-2021) 5.1.3 Artificial Vital Organs and Medical Bionics Price by Application (2016-2021) 5.2 Artificial Vital Organs and Medical Bionics Market Size Forecast by Application (2022-2027) 5.2.1 Global Artificial Vital Organs and Medical Bionics Sales Forecast by Application (2022-2027) 5.2.2 Global Artificial Vital Organs and Medical Bionics Revenue Forecast by Application (2022-2027) 5.2.3 Global Artificial Vital Organs and Medical Bionics Price Forecast by Application (2022-2027) 6 China by Players, Type and Application 6.1 China Artificial Vital Organs and Medical Bionics Market Size YoY Growth 2016-2027 6.1.1 China Artificial Vital Organs and Medical Bionics Sales YoY Growth 2016-2027 6.1.2 China Artificial Vital Organs and Medical Bionics Revenue YoY Growth 2016-2027 6.1.3 China Artificial Vital Organs and Medical Bionics Market Share in Global Market 2016-2027 6.2 China Artificial Vital Organs and Medical Bionics Market Size by Players (International and Local Players) 6.2.1 China Top Artificial Vital Organs and Medical Bionics Players by Sales (2016-2021) 6.2.2 China Top Artificial Vital Organs and Medical Bionics Players by Revenue (2016-2021) 6.3 China Artificial Vital Organs and Medical Bionics Historic Market Review by Type (2016-2021) 6.3.1 China Artificial Vital Organs and Medical Bionics Sales Market Share by Type (2016-2021) 6.3.2 China Artificial Vital Organs and Medical Bionics Revenue Market Share by Type (2016-2021) 6.3.3 China Artificial Vital Organs and Medical Bionics Price by Type (2016-2021) 6.4 China Artificial Vital Organs and Medical Bionics Market Estimates and Forecasts by Type (2022-2027) 6.4.1 China Artificial Vital Organs and Medical Bionics Sales Forecast by Type (2022-2027) 6.4.2 China Artificial Vital Organs and Medical Bionics Revenue Forecast by Type (2022-2027) 6.4.3 China Artificial Vital Organs and Medical Bionics Price Forecast by Type (2022-2027) 6.5 China Artificial Vital Organs and Medical Bionics Historic Market Review by Application (2016-2021) 6.5.1 China Artificial Vital Organs and Medical Bionics Sales Market Share by Application (2016-2021) 6.5.2 China Artificial Vital Organs and Medical Bionics Revenue Market Share by Application (2016-2021) 6.5.3 China Artificial Vital Organs and Medical Bionics Price by Application (2016-2021) 6.6 China Artificial Vital Organs and Medical Bionics Market Estimates and Forecasts by Application (2022-2027) 6.6.1 China Artificial Vital Organs and Medical Bionics Sales Forecast by Application (2022-2027) 6.6.2 China Artificial Vital Organs and Medical Bionics Revenue Forecast by Application (2022-2027) 6.6.3 China Artificial Vital Organs and Medical Bionics Price Forecast by Application (2022-2027) 7 North America 7.1 North America Artificial Vital Organs and Medical Bionics Market Size YoY Growth 2016-2027 7.2 North America Artificial Vital Organs and Medical Bionics Market Facts & Figures by Country 7.2.1 North America Artificial Vital Organs and Medical Bionics Sales by Country (2016-2021) 7.2.2 North America Artificial Vital Organs and Medical Bionics Revenue by Country (2016-2021) 7.2.3 U.S. 7.2.4 Canada 8 Asia Pacific 8.1 Asia Pacific Artificial Vital Organs and Medical Bionics Market Size YoY Growth 2016-2027 8.2 Asia Pacific Artificial Vital Organs and Medical Bionics Market Facts & Figures by Region 8.2.1 Asia Pacific Artificial Vital Organs and Medical Bionics Sales by Region (2016-2021) 8.2.2 Asia Pacific Artificial Vital Organs and Medical Bionics Revenue by Region (2016-2021) 8.2.3 China 8.2.4 Japan 8.2.5 South Korea 8.2.6 India 8.2.7 Australia 8.2.8 Australia 8.2.9 Indonesia 8.2.10 Thailand 8.2.11 Malaysia 8.2.12 Philippines 8.2.13 Vietnam 9 Europe 9.1 Europe Artificial Vital Organs and Medical Bionics Market Size YoY Growth 2016-2027 9.2 Europe Artificial Vital Organs and Medical Bionics Market Facts & Figures by Country 9.2.1 Europe Artificial Vital Organs and Medical Bionics Sales by Country (2016-2021) 9.2.2 Europe Artificial Vital Organs and Medical Bionics Revenue by Country (2016-2021) 9.2.3 Germany 9.2.4 France 9.2.5 U.K. 9.2.6 Italy 10 Latin America 10.1 Latin America Artificial Vital Organs and Medical Bionics Market Size YoY Growth 2016-2027 10.2 Latin America Artificial Vital Organs and Medical Bionics Market Facts & Figures by Country 10.2.1 Latin America Artificial Vital Organs and Medical Bionics Sales by Country (2016-2021) 10.2.2 Latin America Artificial Vital Organs and Medical Bionics Revenue by Country (2016-2021) 10.2.3 Mexico 10.2.4 Brazil 10.2.5 Argentina 11 Middle East and Africa 11.1 Middle East and Africa Artificial Vital Organs and Medical Bionics Market Size YoY Growth 2016-2027 11.2 Middle East and Africa Artificial Vital Organs and Medical Bionics Market Facts & Figures by Country 11.2.1 Middle East and Africa Artificial Vital Organs and Medical Bionics Sales by Country (2016-2021) 11.2.2 Middle East and Africa Artificial Vital Organs and Medical Bionics Revenue by Country (2016-2021) 11.2.3 Turkey 11.2.4 Saudi Arabia 11.2.5 U.A.E 12 Company Profiles 12.1 Abbott 12.1.1 Abbott Corporation Information 12.1.2 Abbott Description and Business Overview 12.1.3 Abbott Artificial Vital Organs and Medical Bionics Sales, Revenue and Gross Margin (2016-2021) 12.1.4 Abbott Artificial Vital Organs and Medical Bionics Products Offered 12.1.5 Abbott Recent Development 12.2 Abiomed, Inc. 12.2.1 Abiomed, Inc. Corporation Information 12.2.2 Abiomed, Inc. Description and Business Overview 12.2.3 Abiomed, Inc. Artificial Vital Organs and Medical Bionics Sales, Revenue and Gross Margin (2016-2021) 12.2.4 Abiomed, Inc. Artificial Vital Organs and Medical Bionics Products Offered 12.2.5 Abiomed, Inc. Recent Development 12.3 Asahi Kasei Medical Co., Ltd. 12.3.1 Asahi Kasei Medical Co., Ltd. Corporation Information 12.3.2 Asahi Kasei Medical Co., Ltd. Description and Business Overview 12.3.3 Asahi Kasei Medical Co., Ltd. Artificial Vital Organs and Medical Bionics Sales, Revenue and Gross Margin (2016-2021) 12.3.4 Asahi Kasei Medical Co., Ltd. Artificial Vital Organs and Medical Bionics Products Offered 12.3.5 Asahi Kasei Medical Co., Ltd. Recent Development 12.4 Baxter 12.4.1 Baxter Corporation Information 12.4.2 Baxter Description and Business Overview 12.4.3 Baxter Artificial Vital Organs and Medical Bionics Sales, Revenue and Gross Margin (2016-2021) 12.4.4 Baxter Artificial Vital Organs and Medical Bionics Products Offered 12.4.5 Baxter Recent Development 12.5 Cyberonics, Inc. 12.5.1 Cyberonics, Inc. Corporation Information 12.5.2 Cyberonics, Inc. Description and Business Overview 12.5.3 Cyberonics, Inc. Artificial Vital Organs and Medical Bionics Sales, Revenue and Gross Margin (2016-2021) 12.5.4 Cyberonics, Inc. Artificial Vital Organs and Medical Bionics Products Offered 12.5.5 Cyberonics, Inc. Recent Development 12.6 Edwards 12.6.1 Edwards Corporation Information 12.6.2 Edwards Description and Business Overview 12.6.3 Edwards Artificial Vital Organs and Medical Bionics Sales, Revenue and Gross Margin (2016-2021) 12.6.4 Edwards Artificial Vital Organs and Medical Bionics Products Offered 12.6.5 Edwards Recent Development 12.7 Ekso Bionics 12.7.1 Ekso Bionics Corporation Information 12.7.2 Ekso Bionics Description and Business Overview 12.7.3 Ekso Bionics Artificial Vital Organs and Medical Bionics Sales, Revenue and Gross Margin (2016-2021) 12.7.4 Ekso Bionics Artificial Vital Organs and Medical Bionics Products Offered 12.7.5 Ekso Bionics Recent Development 12.8 Roche 12.8.1 Roche Corporation Information 12.8.2 Roche Description and Business Overview 12.8.3 Roche Artificial Vital Organs and Medical Bionics Sales, Revenue and Gross Margin (2016-2021) 12.8.4 Roche Artificial Vital Organs and Medical Bionics Products Offered 12.8.5 Roche Recent Development 12.9 Fresenius 12.9.1 Fresenius Corporation Information 12.9.2 Fresenius Description and Business Overview 12.9.3 Fresenius Artificial Vital Organs and Medical Bionics Sales, Revenue and Gross Margin (2016-2021) 12.9.4 Fresenius Artificial Vital Organs and Medical Bionics Products Offered 12.9.5 Fresenius Recent Development 12.10 Baxter International 12.10.1 Baxter International Corporation Information 12.10.2 Baxter International Description and Business Overview 12.10.3 Baxter International Artificial Vital Organs and Medical Bionics Sales, Revenue and Gross Margin (2016-2021) 12.10.4 Baxter International Artificial Vital Organs and Medical Bionics Products Offered 12.10.5 Baxter International Recent Development 12.11 Abbott 12.11.1 Abbott Corporation Information 12.11.2 Abbott Description and Business Overview 12.11.3 Abbott Artificial Vital Organs and Medical Bionics Sales, Revenue and Gross Margin (2016-2021) 12.11.4 Abbott Artificial Vital Organs and Medical Bionics Products Offered 12.11.5 Abbott Recent Development 12.12 Jarvik Heart 12.12.1 Jarvik Heart Corporation Information 12.12.2 Jarvik Heart Description and Business Overview 12.12.3 Jarvik Heart Artificial Vital Organs and Medical Bionics Sales, Revenue and Gross Margin (2016-2021) 12.12.4 Jarvik Heart Products Offered 12.12.5 Jarvik Heart Recent Development 12.13 Medtronic 12.13.1 Medtronic Corporation Information 12.13.2 Medtronic Description and Business Overview 12.13.3 Medtronic Artificial Vital Organs and Medical Bionics Sales, Revenue and Gross Margin (2016-2021) 12.13.4 Medtronic Products Offered 12.13.5 Medtronic Recent Development 12.14 Micromed Cardiovascular 12.14.1 Micromed Cardiovascular Corporation Information 12.14.2 Micromed Cardiovascular Description and Business Overview 12.14.3 Micromed Cardiovascular Artificial Vital Organs and Medical Bionics Sales, Revenue and Gross Margin (2016-2021) 12.14.4 Micromed Cardiovascular Products Offered 12.14.5 Micromed Cardiovascular Recent Development 12.15 Nikkiso 12.15.1 Nikkiso Corporation Information 12.15.2 Nikkiso Description and Business Overview 12.15.3 Nikkiso Artificial Vital Organs and Medical Bionics Sales, Revenue and Gross Margin (2016-2021) 12.15.4 Nikkiso Products Offered 12.15.5 Nikkiso Recent Development 12.16 Ossur Hf 12.16.1 Ossur Hf Corporation Information 12.16.2 Ossur Hf Description and Business Overview 12.16.3 Ossur Hf Artificial Vital Organs and Medical Bionics Sales, Revenue and Gross Margin (2016-2021) 12.16.4 Ossur Hf Products Offered 12.16.5 Ossur Hf Recent Development 12.17 Ottobock 12.17.1 Ottobock Corporation Information 12.17.2 Ottobock Description and Business Overview 12.17.3 Ottobock Artificial Vital Organs and Medical Bionics Sales, Revenue and Gross Margin (2016-2021) 12.17.4 Ottobock Products Offered 12.17.5 Ottobock Recent Development 12.18 Second Sight Medical Products, Inc. 12.18.1 Second Sight Medical Products, Inc. Corporation Information 12.18.2 Second Sight Medical Products, Inc. Description and Business Overview 12.18.3 Second Sight Medical Products, Inc. Artificial Vital Organs and Medical Bionics Sales, Revenue and Gross Margin (2016-2021) 12.18.4 Second Sight Medical Products, Inc. Products Offered 12.18.5 Second Sight Medical Products, Inc. Recent Development 12.19 Syncardia Systems, Inc. 12.19.1 Syncardia Systems, Inc. Corporation Information 12.19.2 Syncardia Systems, Inc. Description and Business Overview 12.19.3 Syncardia Systems, Inc. Artificial Vital Organs and Medical Bionics Sales, Revenue and Gross Margin (2016-2021) 12.19.4 Syncardia Systems, Inc. Products Offered 12.19.5 Syncardia Systems, Inc. Recent Development 12.20 Thoratec Corporation 12.20.1 Thoratec Corporation Corporation Information 12.20.2 Thoratec Corporation Description and Business Overview 12.20.3 Thoratec Corporation Artificial Vital Organs and Medical Bionics Sales, Revenue and Gross Margin (2016-2021) 12.20.4 Thoratec Corporation Products Offered 12.20.5 Thoratec Corporation Recent Development 12.21 Touch Bionics, Inc. 12.21.1 Touch Bionics, Inc. Corporation Information 12.21.2 Touch Bionics, Inc. Description and Business Overview 12.21.3 Touch Bionics, Inc. Artificial Vital Organs and Medical Bionics Sales, Revenue and Gross Margin (2016-2021) 12.21.4 Touch Bionics, Inc. Products Offered 12.21.5 Touch Bionics, Inc. Recent Development 12.22 Vital Therapies, Inc. 12.22.1 Vital Therapies, Inc. Corporation Information 12.22.2 Vital Therapies, Inc. Description and Business Overview 12.22.3 Vital Therapies, Inc. Artificial Vital Organs and Medical Bionics Sales, Revenue and Gross Margin (2016-2021) 12.22.4 Vital Therapies, Inc. Products Offered 12.22.5 Vital Therapies, Inc. Recent Development 12.23 WorldHeart Corporation 12.23.1 WorldHeart Corporation Corporation Information 12.23.2 WorldHeart Corporation Description and Business Overview 12.23.3 WorldHeart Corporation Artificial Vital Organs and Medical Bionics Sales, Revenue and Gross Margin (2016-2021) 12.23.4 WorldHeart Corporation Products Offered 12.23.5 WorldHeart Corporation Recent Development 13 Market Opportunities, Challenges, Risks and Influences Factors Analysis 13.1 Artificial Vital Organs and Medical Bionics Industry Trends 13.2 Artificial Vital Organs and Medical Bionics Market Drivers 13.3 Artificial Vital Organs and Medical Bionics Market Challenges 13.4 Artificial Vital Organs and Medical Bionics Market Restraints 14 Value Chain and Sales Channels Analysis 14.1 Value Chain Analysis 14.2 Artificial Vital Organs and Medical Bionics Customers 14.3 Sales Channels Analysis 14.3.1 Sales Channels 14.3.2 Distributors 15 Research Findings and Conclusion 16 Appendix 16.1 Research Methodology 16.1.1 Methodology/Research Approach 16.1.2 Data Source 16.2 Author Details 16.3 Disclaimer
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野の最新刊レポート
QYResearch社のその他分野での最新刊レポート
本レポートと同じKEY WORD(bionics)の最新刊レポート
よくあるご質問QYResearch社はどのような調査会社ですか?QYリサーチ(QYResearch)は幅広い市場を対象に調査・レポート出版を行う、中国に本社をおく調査会社です。 QYResearchでは年間数百タイトルの調査レポートを出版しています。... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
詳細検索
2024/11/20 10:26 155.91 円 165.77 円 200.60 円 |